Teva Branded Pharmaceutical Products R&d Llc

This study tested a monthly injection called fremanezumab to prevent migraines in children and teens aged 6 to 17. Over 500 participants were followed for up to 84 months to check safety and how well the treatment works. The goal was to reduce the number of headache and migraine …

This study tested a new long-acting injectable form of olanzapine (TV-44749) for adults with schizophrenia. The goal was to see if it can control symptoms better than a placebo over 8 weeks. 675 participants took part, and the study also looked at safety and long-term effects up …

This study tested three different slow-release versions of the drug olanzapine given as a shot under the skin. Researchers wanted to see how the drug behaves in the body and whether it is safe. 106 adults with schizophrenia or schizoaffective disorder took part. The goal is to fi…

This study tested a new long-acting olanzapine injection (TV-44749) against the standard oral olanzapine pill in 153 people with schizophrenia. The goal was to see if the shot delivers similar drug levels and is safe. Participants received multiple doses over 21 weeks, with resea…

This study looked at how well and how safely deutetrabenazine works for Chinese adults with Huntington's disease who have chorea (uncontrolled movements). Fifty patients took the drug as part of their normal care. The main goal was to see if chorea scores improved, especially in …

This study tested different versions of the drug TEV-56286 in 47 healthy adults to see how well each is absorbed by the body. Participants took a single dose of each formulation in a random order. The goal was to compare the new formulations to the original capsule and to monitor…